首页 > 最新文献

Life sciences最新文献

英文 中文
LEAP2 modulates β-adrenergic triggered cardiac responses and provokes antihypertensive effects. Leap2调节β-肾上腺素能引发的心脏反应并引起降压作用。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-29 DOI: 10.1016/j.lfs.2026.124243
Sixta Isabel Atencio Berrio, Jhulle Horrane Carvalho, João Batista Dutra, Marcos Eliezeck, Sergio Scalzo, Juliana Vila Verde Ribeiro, Michelle Mendanha Mendonça, Rodrigo Mello Gomes, Gustavo Rodrigues Pedrino, Eduardo Colombari, Daniel Castrogiovanni, Sisti Maria Milagros, Maria Florencia Racioppi, Martin Vila Petroff, Sonia Cantel, Jean-Alain Fehrentz, Silvia Guatimosim, Mario Perelló, Carlos Henrique de Castro, Carlos Henrique Xavier

Receptors for orexigenic hormones are broadly expressed in different tissues. Growth hormone secretagogue receptor (GHSR) is the receptor for the gastric peptide hormone ghrelin, although it further displays an intrinsic ligand-independent activity. The liver-expressed antimicrobial peptide 2 (LEAP2) has been recently identified as GHSR endogenous antagonist and inverse agonist. To understand LEAP2 effects on cardiac performance, we assessed (in-vivo) Wistar (WT) and spontaneously hypertensive rats (SHR), isolated hearts (ex-vivo) and cardiomyocytes (in-vitro). Intravenous LEAP2 injection reduced arterial pressure, with a greater effect in SHR. LEAP2 also reduced cardiac inotropism in both WT and SHR, whereas a negative chronotropy was observed only in SHR. LEAP2 perfusion reduced intraventricular pressure in isolated SHR hearts and attenuated the responses to isoproterenol on coronary flow, whereas responses to acetylcholine were almost unaffected by LEAP2. Fluorescent LEAP2 or ghrelin labeled cardiomyocytes. LEAP2 or the synthetic inverse agonist PF04628935 produced an equipotent reduction in maximum contraction speed, reduced cardiomyocyte shortening area, and attenuated the responses to isoproterenol, but not to acetylcholine. Plasma levels of ghrelin and LEAP2 were not different between strains, but higher GHSR levels were found in SHR hearts. In conclusion, LEAP2 exerted marked cardiovascular effects, reducing arterial pressure and left ventricular systolic performance in both WT and SHR, with a greater impact in hypertensive animals. However, GHSR involvement in SHR cardiac abnormalities is unrelated to the circulating levels of its endogenous ligands and instead seems to depend on altered cardiac GHSR expression and function. The cardiac LEAP2 interaction with β-adrenergic receptors reveals an important cardioprotective potential.

促氧激素受体在不同组织中广泛表达。生长激素促分泌素受体(GHSR)是胃肽激素ghrelin的受体,尽管它进一步显示出内在的不依赖于配体的活性。肝脏表达的抗菌肽2 (LEAP2)最近被确定为GHSR内源性拮抗剂和逆激动剂。为了了解LEAP2对心脏功能的影响,我们评估了(体内)Wistar (WT)和自发性高血压大鼠(SHR)、离体心脏(离体)和心肌细胞(体外)。静脉注射LEAP2可降低动脉压,对SHR的影响更大。LEAP2也降低了WT和SHR的心肌肌力,而仅在SHR中观察到负性时变性。LEAP2灌注降低了离体SHR心脏的室内压,并减弱了异丙肾上腺素对冠状动脉血流的反应,而对乙酰胆碱的反应几乎不受LEAP2的影响。荧光LEAP2或生长素标记的心肌细胞。LEAP2或合成的逆激动剂PF04628935对最大收缩速度和心肌细胞缩短面积产生等效降低,并减弱对异丙肾上腺素的反应,但对乙酰胆碱没有作用。血浆ghrelin和LEAP2水平在菌株之间没有差异,但SHR心脏的GHSR水平较高。综上所述,LEAP2具有明显的心血管作用,可以降低WT和SHR动物的动脉压和左心室收缩性能,其中对高血压动物的影响更大。然而,GHSR参与SHR心脏异常与其内源性配体的循环水平无关,而似乎取决于心脏GHSR表达和功能的改变。心脏LEAP2与β-肾上腺素能受体的相互作用揭示了重要的心脏保护潜力。
{"title":"LEAP2 modulates β-adrenergic triggered cardiac responses and provokes antihypertensive effects.","authors":"Sixta Isabel Atencio Berrio, Jhulle Horrane Carvalho, João Batista Dutra, Marcos Eliezeck, Sergio Scalzo, Juliana Vila Verde Ribeiro, Michelle Mendanha Mendonça, Rodrigo Mello Gomes, Gustavo Rodrigues Pedrino, Eduardo Colombari, Daniel Castrogiovanni, Sisti Maria Milagros, Maria Florencia Racioppi, Martin Vila Petroff, Sonia Cantel, Jean-Alain Fehrentz, Silvia Guatimosim, Mario Perelló, Carlos Henrique de Castro, Carlos Henrique Xavier","doi":"10.1016/j.lfs.2026.124243","DOIUrl":"10.1016/j.lfs.2026.124243","url":null,"abstract":"<p><p>Receptors for orexigenic hormones are broadly expressed in different tissues. Growth hormone secretagogue receptor (GHSR) is the receptor for the gastric peptide hormone ghrelin, although it further displays an intrinsic ligand-independent activity. The liver-expressed antimicrobial peptide 2 (LEAP2) has been recently identified as GHSR endogenous antagonist and inverse agonist. To understand LEAP2 effects on cardiac performance, we assessed (in-vivo) Wistar (WT) and spontaneously hypertensive rats (SHR), isolated hearts (ex-vivo) and cardiomyocytes (in-vitro). Intravenous LEAP2 injection reduced arterial pressure, with a greater effect in SHR. LEAP2 also reduced cardiac inotropism in both WT and SHR, whereas a negative chronotropy was observed only in SHR. LEAP2 perfusion reduced intraventricular pressure in isolated SHR hearts and attenuated the responses to isoproterenol on coronary flow, whereas responses to acetylcholine were almost unaffected by LEAP2. Fluorescent LEAP2 or ghrelin labeled cardiomyocytes. LEAP2 or the synthetic inverse agonist PF04628935 produced an equipotent reduction in maximum contraction speed, reduced cardiomyocyte shortening area, and attenuated the responses to isoproterenol, but not to acetylcholine. Plasma levels of ghrelin and LEAP2 were not different between strains, but higher GHSR levels were found in SHR hearts. In conclusion, LEAP2 exerted marked cardiovascular effects, reducing arterial pressure and left ventricular systolic performance in both WT and SHR, with a greater impact in hypertensive animals. However, GHSR involvement in SHR cardiac abnormalities is unrelated to the circulating levels of its endogenous ligands and instead seems to depend on altered cardiac GHSR expression and function. The cardiac LEAP2 interaction with β-adrenergic receptors reveals an important cardioprotective potential.</p>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":" ","pages":"124243"},"PeriodicalIF":5.1,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146096945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endothelial NLRP3 inflammasome activation drives immunothrombosis in Streptococcus pyogenes infection 内皮NLRP3炎性体激活驱动化脓性链球菌感染的免疫血栓形成。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-29 DOI: 10.1016/j.lfs.2026.124239
Yi-Hsin Lai , Ya-Hui Liu , Jyun-You Chen , Chung-Ta Lee , Shu-Ying Wang , Chuan Chiang-Ni , Yueh-Hsia Luo , Chia-Yu Chi , Takeshi Noda , Shiou-Ling Lu , Yau-Sheng Tsai , Jiunn-Jong Wu , Pei-Jane Tsai
Streptococcus pyogenes (Strep A), a formidable human pathogen, is notorious for causing life-threatening diseases such as necrotizing fasciitis and streptococcal toxic shock syndrome, often complicated by thrombosis and coagulation abnormalities. While macrophage inflammasome activation has been widely studied in Strep A pathogenesis, the contribution of vascular endothelial cells-key regulators of immunity and coagulation-remains largely unexplored. This study aimed to determine whether endothelial NLRP3 inflammasome activation drives immunothrombosis during invasive Strep A infection and to define the roles of streptolysin O (SLO) and streptolysin S (SLS) in this mechanism. Using a murine intramuscular infection model in wild-type and NOD-like receptor family pyrin domain-containing 3 (NLRP3)-deficient mice together with infection of human microvascular endothelial cells with wild-type or toxin-deficient Strep A strains, we found that Strep A robustly activated the endothelial NLRP3 inflammasome, leading to caspase-1 activation, IL-1β secretion, endothelial pyroptosis, and a cascade of immunothrombotic events. Genetic ablation of NLRP3 or pharmacological inhibition of caspase-1 significantly attenuated inflammasome activation, immunothrombosis, and tissue injury. Both SLO and SLS were essential for these pathogenic effects. These findings illuminate a hitherto unrecognized endothelial inflammasome-mediated axis in Strep A infection and pave the way for innovative therapeutic strategies targeting endothelial immune responses to combat invasive streptococcal diseases.
化脓性链球菌(链球菌A)是一种可怕的人类病原体,以引起危及生命的疾病而臭名昭著,如坏死性筋膜炎和链球菌中毒性休克综合征,通常伴有血栓形成和凝血异常。虽然巨噬细胞炎性体活化在甲型链球菌发病机制中已被广泛研究,但血管内皮细胞(免疫和凝血的关键调节因子)的作用仍未得到充分研究。本研究旨在确定浸润性甲型链球菌感染过程中内皮NLRP3炎性小体激活是否驱动免疫血栓形成,并确定溶血素O (SLO)和溶血素S (SLS)在这一机制中的作用。利用野生型和nod样受体家族pyrin - domain-containing 3 (NLRP3)缺陷小鼠肌内感染模型,以及野生型或毒素缺陷链球菌a菌株感染人微血管内皮细胞,我们发现链球菌a强烈激活内皮NLRP3炎性体,导致caspase-1激活、IL-1β分泌、内皮细胞凋亡和一系列免疫血栓形成事件。基因消融NLRP3或药物抑制caspase-1可显著减轻炎性体活化、免疫血栓形成和组织损伤。SLO和SLS对这些致病作用都是必需的。这些发现阐明了迄今为止尚未认识到的a型链球菌感染中内皮炎性小体介导的轴,并为针对内皮免疫反应对抗侵袭性链球菌疾病的创新治疗策略铺平了道路。
{"title":"Endothelial NLRP3 inflammasome activation drives immunothrombosis in Streptococcus pyogenes infection","authors":"Yi-Hsin Lai ,&nbsp;Ya-Hui Liu ,&nbsp;Jyun-You Chen ,&nbsp;Chung-Ta Lee ,&nbsp;Shu-Ying Wang ,&nbsp;Chuan Chiang-Ni ,&nbsp;Yueh-Hsia Luo ,&nbsp;Chia-Yu Chi ,&nbsp;Takeshi Noda ,&nbsp;Shiou-Ling Lu ,&nbsp;Yau-Sheng Tsai ,&nbsp;Jiunn-Jong Wu ,&nbsp;Pei-Jane Tsai","doi":"10.1016/j.lfs.2026.124239","DOIUrl":"10.1016/j.lfs.2026.124239","url":null,"abstract":"<div><div><em>Streptococcus pyogenes</em> (Strep A), a formidable human pathogen, is notorious for causing life-threatening diseases such as necrotizing fasciitis and streptococcal toxic shock syndrome, often complicated by thrombosis and coagulation abnormalities. While macrophage inflammasome activation has been widely studied in Strep A pathogenesis, the contribution of vascular endothelial cells-key regulators of immunity and coagulation-remains largely unexplored. This study aimed to determine whether endothelial NLRP3 inflammasome activation drives immunothrombosis during invasive Strep A infection and to define the roles of streptolysin O (SLO) and streptolysin S (SLS) in this mechanism. Using a murine intramuscular infection model in wild-type and NOD-like receptor family pyrin domain-containing 3 (NLRP3)-deficient mice together with infection of human microvascular endothelial cells with wild-type or toxin-deficient Strep A strains, we found that Strep A robustly activated the endothelial NLRP3 inflammasome, leading to caspase-1 activation, IL-1β secretion, endothelial pyroptosis, and a cascade of immunothrombotic events. Genetic ablation of NLRP3 or pharmacological inhibition of caspase-1 significantly attenuated inflammasome activation, immunothrombosis, and tissue injury. Both SLO and SLS were essential for these pathogenic effects. These findings illuminate a hitherto unrecognized endothelial inflammasome-mediated axis in Strep A infection and pave the way for innovative therapeutic strategies targeting endothelial immune responses to combat invasive streptococcal diseases.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"389 ","pages":"Article 124239"},"PeriodicalIF":5.1,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dose-dependent effects of vildagliptin (DPP-4 inhibitor) in a scopolamine-induced memory impairment model in rats 维格列汀(DPP-4抑制剂)在东莨菪碱诱导的大鼠记忆损伤模型中的剂量依赖性作用。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-29 DOI: 10.1016/j.lfs.2026.124245
Fazilet Şen Metin , Elif Aksöz

Aims

Cognitive decline and dementia are closely linked with metabolic disorders such as type 2 diabetes mellitus, sharing common pathophysiological mechanisms including insulin resistance, inflammation, and oxidative stress. This study investigated the neuroprotective potential of vildagliptin, an antidiabetic medication, in a rat model of scopolamine-induced acute memory impairment, focusing on its effects on learning and memory as well as its association with cholinergic activity, inflammatory responses, and lipid peroxidation as an indicator of oxidative stress.

Materials and methods

Male Wistar Albino rats were orally administered vildagliptin (0.5, 5, or 50 mg/kg/day) or physiological saline for 4 weeks. Spatial learning and memory were assessed using the Morris water maze (MWM) test. Memory impairment was induced by intraperitoneal injection of scopolamine (1 mg/kg, i.p.) before the probe trial of the MWM. Following behavioral testing, rats were sacrificed, and hippocampal tissues were isolated for biochemical analysis.

Key findings

Vildagliptin significantly enhanced spatial learning performance in a dose-dependent manner during the acquisition phase of the MWM. Scopolamine administration markedly impaired memory performance in rats. Pretreatment with vildagliptin at all tested doses prevented these memory deficits during the MWM probe trial. In addition, vildagliptin robustly prevented scopolamine-induced increases in hippocampal acetylcholinesterase (AChE) activity and elevated levels of interleukin-1 beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and malondialdehyde (MDA).

Significance

These findings suggest that vildagliptin may exert protective effects against cognitive impairment by modulating cholinergic activity, inflammatory responses, and lipid peroxidation.
目的:认知能力下降和痴呆与2型糖尿病等代谢性疾病密切相关,具有胰岛素抵抗、炎症和氧化应激等共同的病理生理机制。本研究研究了抗糖尿病药物维格列汀在东莨菪碱诱导的急性记忆损伤大鼠模型中的神经保护潜力,重点研究了它对学习和记忆的影响,以及它与胆碱能活性、炎症反应和脂质过氧化(氧化应激的一个指标)的关联。材料和方法:雄性Wistar Albino大鼠口服维格列汀(0.5、5或50 mg/kg/天)或生理盐水4 周。空间学习记忆采用Morris水迷宫(MWM)测试。在MWM探针试验前,腹腔注射东莨菪碱(1 mg/kg, i.p)诱导记忆损伤。行为学测试结束后,处死大鼠,分离海马组织进行生化分析。主要发现:在MWM的习得阶段,维格列汀以剂量依赖性的方式显著增强了空间学习表现。东莨菪碱显著损害了大鼠的记忆表现。在MWM探针试验期间,所有测试剂量的维格列汀预处理均可防止这些记忆缺陷。此外,维格列汀可有效阻止东莨菪碱诱导的海马乙酰胆碱酯酶(AChE)活性升高和白细胞介素-1β (IL-1β)、白细胞介素-6 (IL-6)、肿瘤坏死因子-α (TNF-α)和丙二醛(MDA)水平升高。意义:这些发现提示维格列汀可能通过调节胆碱能活性、炎症反应和脂质过氧化来发挥对认知障碍的保护作用。
{"title":"Dose-dependent effects of vildagliptin (DPP-4 inhibitor) in a scopolamine-induced memory impairment model in rats","authors":"Fazilet Şen Metin ,&nbsp;Elif Aksöz","doi":"10.1016/j.lfs.2026.124245","DOIUrl":"10.1016/j.lfs.2026.124245","url":null,"abstract":"<div><h3>Aims</h3><div>Cognitive decline and dementia are closely linked with metabolic disorders such as type 2 diabetes mellitus, sharing common pathophysiological mechanisms including insulin resistance, inflammation, and oxidative stress. This study investigated the neuroprotective potential of vildagliptin, an antidiabetic medication, in a rat model of scopolamine-induced acute memory impairment, focusing on its effects on learning and memory as well as its association with cholinergic activity, inflammatory responses, and lipid peroxidation as an indicator of oxidative stress.</div></div><div><h3>Materials and methods</h3><div>Male Wistar Albino rats were orally administered vildagliptin (0.5, 5, or 50 mg/kg/day) or physiological saline for 4 weeks. Spatial learning and memory were assessed using the Morris water maze (MWM) test. Memory impairment was induced by intraperitoneal injection of scopolamine (1 mg/kg, <em>i.p.</em>) before the probe trial of the MWM. Following behavioral testing, rats were sacrificed, and hippocampal tissues were isolated for biochemical analysis.</div></div><div><h3>Key findings</h3><div>Vildagliptin significantly enhanced spatial learning performance in a dose-dependent manner during the acquisition phase of the MWM. Scopolamine administration markedly impaired memory performance in rats. Pretreatment with vildagliptin at all tested doses prevented these memory deficits during the MWM probe trial. In addition, vildagliptin robustly prevented scopolamine-induced increases in hippocampal acetylcholinesterase (AChE) activity and elevated levels of interleukin-1 beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and malondialdehyde (MDA).</div></div><div><h3>Significance</h3><div>These findings suggest that vildagliptin may exert protective effects against cognitive impairment by modulating cholinergic activity, inflammatory responses, and lipid peroxidation.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"389 ","pages":"Article 124245"},"PeriodicalIF":5.1,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146097032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gestational sevoflurane exposure induces amino acid metabolic reprogramming and cognitive deficits in offspring 妊娠期七氟醚暴露诱导后代氨基酸代谢重编程和认知缺陷
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-29 DOI: 10.1016/j.lfs.2026.124246
Jieyu Ma , Li Xu , Nai Sun , Jianqiang Song , Jie Wang , Jingjing Wang , Liumei Li , Qinjun Chu , Lin-jian Wang , Qiong Song

Background

Sevoflurane is one of the most widely used anesthetics in pediatric medicine; however, accumulating evidence raises critical concerns regarding its potential to induce long-term neurodevelopmental deficits. Despite extensive research, the underlying systemic molecular mechanisms driving these outcomes remain elusive.

Methods

Pregnant C57BL/6J mice were exposed to 2.5% sevoflurane for 2 h at embryonic day 14 (E14). Offspring were assessed for spatial learning and anxiety-related behaviors. To reconstruct the molecular landscape of toxicity, we employed an integrative multi-omics approach combining transcriptomics, proteomics, and paired brain–serum metabolomics, complemented by ELISA validation and histopathology.

Results

Sevoflurane-exposed offspring exhibited persistent spatial learning deficits and anxiety-like behaviors. These functional impairments were mirrored by histopathological damage, characterized by disordered neuronal arrangement and reduced Nissl-positive cells in the hippocampus. Consistently, ELISA analysis revealed a pronounced systemic inflammatory response (elevated IL-1β, IL-6, TNF-α). Integrated multi-omics profiling uncovered the molecular basis of these phenotypes, revealing a landscape of neurodevelopmental gene suppression alongside the activation of oxidative stress and inflammatory signaling. Underpinning these multidimensional pathologies, we identified a convergent reprogramming of amino acid metabolism, defined by glutamate depletion and lysine accumulation—metabolic shifts previously implicated in neuroinflammation and cognitive decline. Finally, ectoine and 5-OPPA were consistently depleted in both brain and serum, identifying them as novel concordant biomarkers of anesthetic neurotoxicity.

Conclusions

These findings demonstrate that gestational sevoflurane exposure induces persistent neurocognitive dysfunction in offspring driven by amino acid metabolic reprogramming. The concordant depletion of ectoine and 5-OPPA highlights their potential as minimally invasive biomarkers for anesthetic induced neurodevelopmental injury.
背景七氟醚是儿科医学中应用最广泛的麻醉药之一;然而,越来越多的证据引起了人们对其可能导致长期神经发育缺陷的担忧。尽管进行了广泛的研究,但驱动这些结果的潜在系统分子机制仍然难以捉摸。方法C57BL/6J妊娠小鼠在胚胎第14天(E14)暴露于2.5%七氟醚2 h。评估后代的空间学习和焦虑相关行为。为了重建毒性的分子景观,我们采用了综合多组学方法,结合转录组学、蛋白质组学和配对脑血清代谢组学,辅以ELISA验证和组织病理学。结果七氟醚暴露后代表现出持续性空间学习缺陷和焦虑样行为。这些功能损伤反映在组织病理学损伤上,其特征是神经元排列紊乱和海马中nsil阳性细胞减少。与此一致,ELISA分析显示明显的全身炎症反应(IL-1β, IL-6, TNF-α升高)。综合多组学分析揭示了这些表型的分子基础,揭示了神经发育基因抑制以及氧化应激和炎症信号的激活。在这些多维病理的基础上,我们确定了氨基酸代谢的趋同重编程,由谷氨酸消耗和赖氨酸积累定义-代谢变化先前涉及神经炎症和认知能力下降。最后,脑和血清中的异托因和5-OPPA持续减少,确定它们是麻醉神经毒性的新的一致生物标志物。结论妊娠期暴露于七氟醚可引起氨基酸代谢重编程驱动的后代持续性神经认知功能障碍。外托碱和5-OPPA的一致耗竭突出了它们作为麻醉诱导的神经发育损伤的微创生物标志物的潜力。
{"title":"Gestational sevoflurane exposure induces amino acid metabolic reprogramming and cognitive deficits in offspring","authors":"Jieyu Ma ,&nbsp;Li Xu ,&nbsp;Nai Sun ,&nbsp;Jianqiang Song ,&nbsp;Jie Wang ,&nbsp;Jingjing Wang ,&nbsp;Liumei Li ,&nbsp;Qinjun Chu ,&nbsp;Lin-jian Wang ,&nbsp;Qiong Song","doi":"10.1016/j.lfs.2026.124246","DOIUrl":"10.1016/j.lfs.2026.124246","url":null,"abstract":"<div><h3>Background</h3><div>Sevoflurane is one of the most widely used anesthetics in pediatric medicine; however, accumulating evidence raises critical concerns regarding its potential to induce long-term neurodevelopmental deficits. Despite extensive research, the underlying systemic molecular mechanisms driving these outcomes remain elusive.</div></div><div><h3>Methods</h3><div>Pregnant C57BL/6J mice were exposed to 2.5% sevoflurane for 2 h at embryonic day 14 (E14). Offspring were assessed for spatial learning and anxiety-related behaviors. To reconstruct the molecular landscape of toxicity, we employed an integrative multi-omics approach combining transcriptomics, proteomics, and paired brain–serum metabolomics, complemented by ELISA validation and histopathology.</div></div><div><h3>Results</h3><div>Sevoflurane-exposed offspring exhibited persistent spatial learning deficits and anxiety-like behaviors. These functional impairments were mirrored by histopathological damage, characterized by disordered neuronal arrangement and reduced Nissl-positive cells in the hippocampus. Consistently, ELISA analysis revealed a pronounced systemic inflammatory response (elevated IL-1β, IL-6, TNF-α). Integrated multi-omics profiling uncovered the molecular basis of these phenotypes, revealing a landscape of neurodevelopmental gene suppression alongside the activation of oxidative stress and inflammatory signaling. Underpinning these multidimensional pathologies, we identified a convergent reprogramming of amino acid metabolism, defined by glutamate depletion and lysine accumulation—metabolic shifts previously implicated in neuroinflammation and cognitive decline. Finally, ectoine and 5-OPPA were consistently depleted in both brain and serum, identifying them as novel concordant biomarkers of anesthetic neurotoxicity.</div></div><div><h3>Conclusions</h3><div>These findings demonstrate that gestational sevoflurane exposure induces persistent neurocognitive dysfunction in offspring driven by amino acid metabolic reprogramming. The concordant depletion of ectoine and 5-OPPA highlights their potential as minimally invasive biomarkers for anesthetic induced neurodevelopmental injury.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"389 ","pages":"Article 124246"},"PeriodicalIF":5.1,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146080719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HHcy promotes hypertension by activating ferroptosis via suppression of the renal H₂S-SLC7A11/GPX4 axis HHcy通过抑制肾H₂S-SLC7A11/GPX4轴激活铁下垂来促进高血压。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-29 DOI: 10.1016/j.lfs.2026.124247
Pan Huang , Kexin Zhang , Ying Chen , Jiaxin Cheng , Shuangshuang Yang , Lin Shi , Yajuan Wang , Qin Zhang
Elevated homocysteine (Hcy) is an independent risk factor for hypertension, and kidney is an important organ for Hcy metabolism and blood pressure regulation, and its damage is closely related to the process of hypertension. Recent evidence suggests that ferroptosis, an oxidative stress-related form of cell death, contributes significantly to hypertensive organ damage. However, whether Hcy aggravates renal injury in H-type hypertension by destroying renal hydrogen sulfide (H2S) metabolism and driving ferroptosis is still lack of direct evidence. In this study, the H-type hypertensive rat model induced by high methionine diet combined with HK-2 cell model was studied. We observed a significant increase in blood pressure and plasma Hcy in the Hcy group, accompanied by renal dysfunction and renal tubular injury. Specifically, in the renal tissue of Hcy group rats, the levels of KIM-1, Fe2+ and malondialdehyde (MDA) were increased, glutathione/glutathione disulfide (GSH/GSSG) ratio decreased, SLC7A11 expression was down-regulated, and GPX4 activity was inhibited. Concurrently, H2S levels and cystathionine-beta-synthase (CBS) activity were decreased. In vitro experiments using HK-2 cells confirmed that Hcy could down-regulate the expression of CBS, cystathionine-gamma-lyase (CSE), SLC7A11, GPX4 and GSH/GSSG ratio, and up-regulate MDA and reactive oxygen species (ROS) levels. Treatment with H2S donor (NaHS) or ferroptosis inhibitors (Ferrostatin-1, Fer-1) could rescue these changes. Collectively, our results demonstrate that high Hcy promotes hypertension by suppressing endogenous H2S generation, downregulating the SLC7A11/GPX4 signaling axis, and inducing ferroptosis. These findings reveal a new mechanism by which Hcy aggravates hypertension by inhibiting H2S synthesis and inducing ferroptosis.
高同型半胱氨酸(Hcy)是高血压的独立危险因素,肾脏是Hcy代谢和血压调节的重要器官,其损害与高血压的发生过程密切相关。最近的证据表明,铁下垂是一种氧化应激相关的细胞死亡形式,对高血压器官损伤有重要作用。然而,Hcy是否通过破坏肾脏硫化氢(H2S)代谢,导致铁下垂而加重h型高血压的肾损伤,目前尚缺乏直接证据。本研究采用高蛋氨酸饮食联合HK-2细胞模型建立h型高血压大鼠模型。我们观察到Hcy组血压和血浆Hcy显著升高,并伴有肾功能障碍和肾小管损伤。Hcy组大鼠肾组织中KIM-1、Fe2+、丙二醛(MDA)水平升高,谷胱甘肽/谷胱甘肽二硫(GSH/GSSG)比值降低,SLC7A11表达下调,GPX4活性受到抑制。同时,H2S水平和胱硫氨酸- β合成酶(CBS)活性降低。体外HK-2细胞实验证实,Hcy可下调CBS、胱硫氨酸- γ -裂解酶(CSE)、SLC7A11、GPX4和GSH/GSSG比值的表达,上调MDA和活性氧(ROS)水平。用H2S供体(NaHS)或铁下垂抑制剂(铁抑素-1、铁抑素-1)治疗可以挽救这些变化。总之,我们的研究结果表明,高Hcy通过抑制内源性H2S生成、下调SLC7A11/GPX4信号轴和诱导铁下垂来促进高血压。这些发现揭示了Hcy通过抑制H2S合成和诱导铁下垂加重高血压的新机制。
{"title":"HHcy promotes hypertension by activating ferroptosis via suppression of the renal H₂S-SLC7A11/GPX4 axis","authors":"Pan Huang ,&nbsp;Kexin Zhang ,&nbsp;Ying Chen ,&nbsp;Jiaxin Cheng ,&nbsp;Shuangshuang Yang ,&nbsp;Lin Shi ,&nbsp;Yajuan Wang ,&nbsp;Qin Zhang","doi":"10.1016/j.lfs.2026.124247","DOIUrl":"10.1016/j.lfs.2026.124247","url":null,"abstract":"<div><div>Elevated homocysteine (Hcy) is an independent risk factor for hypertension, and kidney is an important organ for Hcy metabolism and blood pressure regulation, and its damage is closely related to the process of hypertension. Recent evidence suggests that ferroptosis, an oxidative stress-related form of cell death, contributes significantly to hypertensive organ damage. However, whether Hcy aggravates renal injury in H-type hypertension by destroying renal hydrogen sulfide (H<sub>2</sub>S) metabolism and driving ferroptosis is still lack of direct evidence. In this study, the H-type hypertensive rat model induced by high methionine diet combined with HK-2 cell model was studied. We observed a significant increase in blood pressure and plasma Hcy in the Hcy group, accompanied by renal dysfunction and renal tubular injury. Specifically, in the renal tissue of Hcy group rats, the levels of KIM-1, Fe<sup>2+</sup> and malondialdehyde (MDA) were increased, glutathione/glutathione disulfide (GSH/GSSG) ratio decreased, SLC7A11 expression was down-regulated, and GPX4 activity was inhibited. Concurrently, H<sub>2</sub>S levels and cystathionine-beta-synthase (CBS) activity were decreased. In vitro experiments using HK-2 cells confirmed that Hcy could down-regulate the expression of CBS, cystathionine-gamma-lyase (CSE), SLC7A11, GPX4 and GSH/GSSG ratio, and up-regulate MDA and reactive oxygen species (ROS) levels. Treatment with H<sub>2</sub>S donor (NaHS) or ferroptosis inhibitors (Ferrostatin-1, Fer-1) could rescue these changes. Collectively, our results demonstrate that high Hcy promotes hypertension by suppressing endogenous H<sub>2</sub>S generation, downregulating the SLC7A11/GPX4 signaling axis, and inducing ferroptosis. These findings reveal a new mechanism by which Hcy aggravates hypertension by inhibiting H<sub>2</sub>S synthesis and inducing ferroptosis.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"389 ","pages":"Article 124247"},"PeriodicalIF":5.1,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise alleviates the obesity-related dysfunction of skeletal muscle and heart caused by Akh gene knockdown in Drosophila 运动可减轻果蝇Akh基因敲低引起的肥胖相关骨骼肌和心脏功能障碍。
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-29 DOI: 10.1016/j.lfs.2026.124237
Ying Lin , Deng-tai Wen , Qing-yao Sun , Shou-zhi Lv , Ji-ying Wang , Xing-feng Ma
The Adipokinetic hormone (Akh), a functional analog of mammalian glucagon, plays a key role in regulating energy metabolism in Drosophila. Although exercise is recognized as an important intervention for preventing and alleviating obesity-related complications, its efficacy against obesity induced by Akh gene deficiency remains unclear. In this study, the Akh gene was knocked down systemically and specifically in the corpora cardiaca (CC) using Act-gal4/Akh-UAS-RNAi and Akh-gal4/Akh-UAS-RNAi systems in flies, and these flies were followed by a two-week exercise intervention. The results showed Akh knockdown induced obesity phenotypes, including significantly increased body weight and triglyceride levels, and concurrently impaired skeletal muscle and cardiac function—manifested as reduced climbing speed, climbing endurance, and cardiac shortening fraction, along with elevated heart rate. Mechanistically, these effects were associated with upregulated systemic FASN1/Mdy/triglyceride process and lipotoxicity (MDA), as well as downregulated mitochondrial (PGC-1α) and contractile (Mhc) markers in muscle. Exercise intervention ameliorated the obesity phenotype and was correlated with increased Akh expression. These findings confirm that Akh gene deficiency contributes to hereditary obesity and obesity-related dysfunction of skeletal muscle and heart, and demonstrate that exercise can serve as a therapeutic strategy to counteract impairments resulting from Akh knockdown, suggesting its potential relevance for treating human obesity linked to glucagon-related genetic defects.
脂肪动力学激素(Adipokinetic hormone, Akh)是哺乳动物胰高血糖素的功能类似物,在调节果蝇的能量代谢中起关键作用。虽然运动被认为是预防和减轻肥胖相关并发症的重要干预措施,但其对Akh基因缺乏引起的肥胖的疗效尚不清楚。在这项研究中,使用Act-gal4/ ah - uas - rnai和ah -gal4/ ah - uas - rnai系统在果蝇的心体(CC)中系统性和特异性地敲除Akh基因,并对这些果蝇进行为期两周的运动干预。结果显示,Akh敲低诱导肥胖表型,包括体重和甘油三酯水平显著增加,同时骨骼肌和心功能受损,表现为攀登速度、攀登耐力和心脏缩短分数降低,以及心率升高。在机制上,这些影响与全身FASN1/Mdy/甘油三酯过程和脂毒性(MDA)上调以及线粒体(PGC-1α)和肌肉收缩(Mhc)标志物下调有关。运动干预可改善肥胖表型,并与Akh表达增加相关。这些发现证实了Akh基因缺失导致遗传性肥胖和与肥胖相关的骨骼肌和心脏功能障碍,并表明运动可以作为一种治疗策略来抵消Akh基因缺失导致的损伤,这表明它与治疗与胰高血糖素相关的遗传缺陷有关的人类肥胖有潜在的相关性。
{"title":"Exercise alleviates the obesity-related dysfunction of skeletal muscle and heart caused by Akh gene knockdown in Drosophila","authors":"Ying Lin ,&nbsp;Deng-tai Wen ,&nbsp;Qing-yao Sun ,&nbsp;Shou-zhi Lv ,&nbsp;Ji-ying Wang ,&nbsp;Xing-feng Ma","doi":"10.1016/j.lfs.2026.124237","DOIUrl":"10.1016/j.lfs.2026.124237","url":null,"abstract":"<div><div>The Adipokinetic hormone (Akh), a functional analog of mammalian glucagon, plays a key role in regulating energy metabolism in <em>Drosophila</em>. Although exercise is recognized as an important intervention for preventing and alleviating obesity-related complications, its efficacy against obesity induced by <em>Akh</em> gene deficiency remains unclear. In this study, the <em>Akh</em> gene was knocked down systemically and specifically in the corpora cardiaca (CC) using <em>Act-gal4/Akh-UAS-RNAi</em> and <em>Akh-gal4/Akh-UAS-RNAi</em> systems in flies, and these flies were followed by a two-week exercise intervention. The results showed <em>Akh</em> knockdown induced obesity phenotypes, including significantly increased body weight and triglyceride levels, and concurrently impaired skeletal muscle and cardiac function—manifested as reduced climbing speed, climbing endurance, and cardiac shortening fraction, along with elevated heart rate. Mechanistically, these effects were associated with upregulated systemic <em>FASN1</em>/<em>Mdy</em>/triglyceride process and lipotoxicity (MDA), as well as downregulated mitochondrial (<em>PGC-1α</em>) and contractile (<em>Mhc</em>) markers in muscle. Exercise intervention ameliorated the obesity phenotype and was correlated with increased <em>Akh</em> expression. These findings confirm that <em>Akh</em> gene deficiency contributes to hereditary obesity and obesity-related dysfunction of skeletal muscle and heart, and demonstrate that exercise can serve as a therapeutic strategy to counteract impairments resulting from <em>Akh</em> knockdown, suggesting its potential relevance for treating human obesity linked to glucagon-related genetic defects.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"389 ","pages":"Article 124237"},"PeriodicalIF":5.1,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146096947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Loss of Galectin-3 in the epidermis exacerbates psoriasis pathogenesis via inhibiting autophagy 表皮中半乳糖凝集素-3的缺失通过抑制自噬加剧了银屑病的发病机制
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-28 DOI: 10.1016/j.lfs.2026.124238
Shanshan Han , Meiqi Cheng , Shengtao Jiang , Pei Liu , Yue Hu , Qiong Wang , Yu Cai , Yinhong Song , Xuan Xia , Yuxin Wang , Yang Li , Jin Chao , Decheng Wang

Aims

Galectin-3 (Gal3) is linked to psoriasis pathophysiology, however, the detailed mechanism of Gal3 involved in this course still needs further addressing. This study aimed to elucidate the role of Gal3 in psoriasis.

Materials and methods

Imiquimod (IMQ)-induced psoriasis model in wild-type (WT) as well as Gal3 knockout (Gal3−/−) mice were established to investigate the impact of Gal3 expression on the development of psoriasis. Autophagy markers LC3 and P62 (SQSTM1) were detected. In vitro, HaCaT cells with Gal3 knockdown were established to detect the effect on the autophagic flux. Then the Sirt1 agonist SRT1720 was used to demonstrate whether Gal3 affects autophagy via Sirt1. The regulation of Sirt1 by Gal3 was demonstrated through half-life experiments.

Key findings

Gal3 was significantly reduced in the epidermis in IMQ-induced psoriasis model. The skin inflammation in Gal3−/− mice more severe than that in WT controls. A deficiency of Gal3 not only reduced the autophagy in psoriatic lesions of the mice model but also effectively inhibited autophagy in a cultured HaCaT cell model. Gal3 was demonstrated to be involved in the assembly of autophagosomes by regulating autophagic flux. In Gal3-depleted mouse skin and HaCaT cells, Sirt1 was downregulated, and SRT1720 could compensate for the impaired autophagy caused by Gal3 deficiency. Gal3 may be involved in the regulation of Sirt1 protein stability.

Significance

Gal3 loss exacerbates psoriasis by impairing the autophagic process. These findings position Gal3 as a key protective factor against psoriasis, providing new insights into its role in the pathogenesis of this disease.
目的galectin -3 (Gal3)与银屑病的病理生理有关,但Gal3在这一过程中的具体机制还有待进一步研究。本研究旨在阐明Gal3在银屑病中的作用。材料与方法建立咪喹莫特(IMQ)诱导的野生型(WT)和Gal3敲除(Gal3−/−)小鼠银屑病模型,研究Gal3表达对银屑病发展的影响。检测自噬标志物LC3和P62 (SQSTM1)。体外建立敲低Gal3的HaCaT细胞,检测其对自噬通量的影响。然后使用Sirt1激动剂SRT1720来证明Gal3是否通过Sirt1影响自噬。通过半衰期实验证实了Gal3对Sirt1的调控作用。主要发现:imq诱导的银屑病模型中表皮gal3显著降低。Gal3−/−小鼠的皮肤炎症较WT对照组严重。缺乏Gal3不仅可以减少小鼠银屑病模型的自噬,还可以有效抑制培养的HaCaT细胞模型的自噬。研究证实Gal3通过调节自噬通量参与自噬体的组装。在Gal3缺失的小鼠皮肤和HaCaT细胞中,Sirt1下调,SRT1720可以补偿Gal3缺失导致的自噬受损。Gal3可能参与Sirt1蛋白稳定性的调控。egal3丢失通过损害自噬过程加重银屑病。这些发现表明Gal3是预防牛皮癣的关键保护因子,为其在牛皮癣发病机制中的作用提供了新的见解。
{"title":"Loss of Galectin-3 in the epidermis exacerbates psoriasis pathogenesis via inhibiting autophagy","authors":"Shanshan Han ,&nbsp;Meiqi Cheng ,&nbsp;Shengtao Jiang ,&nbsp;Pei Liu ,&nbsp;Yue Hu ,&nbsp;Qiong Wang ,&nbsp;Yu Cai ,&nbsp;Yinhong Song ,&nbsp;Xuan Xia ,&nbsp;Yuxin Wang ,&nbsp;Yang Li ,&nbsp;Jin Chao ,&nbsp;Decheng Wang","doi":"10.1016/j.lfs.2026.124238","DOIUrl":"10.1016/j.lfs.2026.124238","url":null,"abstract":"<div><h3>Aims</h3><div>Galectin-3 (Gal3) is linked to psoriasis pathophysiology, however, the detailed mechanism of Gal3 involved in this course still needs further addressing. This study aimed to elucidate the role of Gal3 in psoriasis.</div></div><div><h3>Materials and methods</h3><div>Imiquimod (IMQ)-induced psoriasis model in wild-type (WT) as well as Gal3 knockout (<em>Gal3</em><sup>−/−</sup>) mice were established to investigate the impact of Gal3 expression on the development of psoriasis. Autophagy markers LC3 and P62 (SQSTM1) were detected. In vitro, HaCaT cells with Gal3 knockdown were established to detect the effect on the autophagic flux. Then the Sirt1 agonist SRT1720 was used to demonstrate whether Gal3 affects autophagy via Sirt1. The regulation of Sirt1 by Gal3 was demonstrated through half-life experiments.</div></div><div><h3>Key findings</h3><div>Gal3 was significantly reduced in the epidermis in IMQ-induced psoriasis model. The skin inflammation in <em>Gal3</em><sup>−/−</sup> mice more severe than that in WT controls. A deficiency of Gal3 not only reduced the autophagy in psoriatic lesions of the mice model but also effectively inhibited autophagy in a cultured HaCaT cell model. Gal3 was demonstrated to be involved in the assembly of autophagosomes by regulating autophagic flux. In Gal3-depleted mouse skin and HaCaT cells, Sirt1 was downregulated, and SRT1720 could compensate for the impaired autophagy caused by Gal3 deficiency. Gal3 may be involved in the regulation of Sirt1 protein stability.</div></div><div><h3>Significance</h3><div>Gal3 loss exacerbates psoriasis by impairing the autophagic process. These findings position Gal3 as a key protective factor against psoriasis, providing new insights into its role in the pathogenesis of this disease.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"389 ","pages":"Article 124238"},"PeriodicalIF":5.1,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146080720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-intensity interval training attenuates the progression of diastolic and skeletal muscle dysfunction in the two-hit mouse model of HFpEF 高强度间歇训练可减轻HFpEF小鼠模型中舒张肌和骨骼肌功能障碍的进展
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-28 DOI: 10.1016/j.lfs.2026.124248
Francisco Pino-De la Fuente , Mayarling F. Troncoso , Sebastián Urquiza-Zurich , David Silva , Magda C. Díaz-Vesga , Danica Jiménez-Gallegos , Rocío Bascuñan , Angélica Ortega-Muñoz , Raúl Vivar , Claudia Muñoz-Rodriguez , Raúl Flores-Vergara , Alejandra Hernández , Alejandra Guerrero-Moncayo , Ximena Calle-Chalco , Pablo F. Castro , Luigi Gabrielli , Mario Chiong , Rodrigo Troncoso , Luis Michea , Sergio Lavandero

Background

Heart failure with preserved ejection fraction (HFpEF) is a multifactorial syndrome characterized by diastolic dysfunction, metabolic disturbances, and skeletal muscle impairments. Exercise training has been recommended as non-pharmacological therapy for HFpEF. Yet its effects on cardiac, renal, skeletal muscle, and metabolic homeostasis remain incompletely understood.

Aim

We investigated the systemic effects of exercise training in the “two-hit” mouse model of HFpEF.

Methods

Male C57BL/6 N mice were assigned to either a sedentary HFpEF group (20 weeks) (n = 10) or a high-intensity interval training (HIIT) intervention for five weeks (training was initiated in the 15th week of the protocol) (n = 10), and a control group (n = 8). Cardiac function was assessed via echocardiography, while glucose metabolism, renal function, and skeletal muscle adaptations were evaluated through metabolic assays, histological analyses, and molecular studies.

Results

HIIT reduced diastolic dysfunction, as indicated by a slightly lower E/e′ ratio and reduced myocardial collagen deposition. Skeletal muscle integrity was improved, with a higher proportion of oxidative fibers in the gastrocnemius, while the quadriceps showed hypertrophy in both oxidative and less oxidative fibers. It also promotes an anabolic environment and mitochondrial enhancement. Force generation was also increased. Furthermore, HIIT reduced insulin levels without affecting renal function but decreased markers of kidney damage.

Conclusions

These findings demonstrate that HIIT attenuates diastolic and skeletal muscle dysfunction in the two-hit HFpEF mice model. Understanding how exercise training influences HFpEF phenotypes could provide novel insights into therapeutic strategies for patients with cardiovascular and metabolic comorbidities.
背景:心力衰竭伴射血分数保留(HFpEF)是一种多因素综合征,以舒张功能障碍、代谢紊乱和骨骼肌损伤为特征。运动训练被推荐为HFpEF的非药物治疗方法。然而,其对心脏、肾脏、骨骼肌和代谢稳态的影响仍不完全清楚。我们研究了运动训练对HFpEF小鼠模型的全身性影响。方法将体型较小的C57BL/ 6n小鼠分为静坐HFpEF组(20周)(N = 10)、高强度间歇训练(HIIT)干预组(在方案的第15周开始训练)(N = 10)和对照组(N = 8)。通过超声心动图评估心功能,通过代谢分析、组织学分析和分子研究评估葡萄糖代谢、肾功能和骨骼肌适应性。结果shiit降低了舒张功能障碍,E/ E比值略低,心肌胶原沉积减少。骨骼肌完整性得到改善,腓肠肌氧化纤维比例较高,而股四头肌氧化纤维和较少氧化纤维均出现肥大。它还促进合成代谢环境和线粒体增强。力的产生也增加了。此外,HIIT在不影响肾功能的情况下降低了胰岛素水平,但降低了肾损伤标志物。结论HIIT可减轻双打击HFpEF小鼠模型的舒张功能和骨骼肌功能障碍。了解运动训练如何影响HFpEF表型可以为心血管和代谢合并症患者的治疗策略提供新的见解。
{"title":"High-intensity interval training attenuates the progression of diastolic and skeletal muscle dysfunction in the two-hit mouse model of HFpEF","authors":"Francisco Pino-De la Fuente ,&nbsp;Mayarling F. Troncoso ,&nbsp;Sebastián Urquiza-Zurich ,&nbsp;David Silva ,&nbsp;Magda C. Díaz-Vesga ,&nbsp;Danica Jiménez-Gallegos ,&nbsp;Rocío Bascuñan ,&nbsp;Angélica Ortega-Muñoz ,&nbsp;Raúl Vivar ,&nbsp;Claudia Muñoz-Rodriguez ,&nbsp;Raúl Flores-Vergara ,&nbsp;Alejandra Hernández ,&nbsp;Alejandra Guerrero-Moncayo ,&nbsp;Ximena Calle-Chalco ,&nbsp;Pablo F. Castro ,&nbsp;Luigi Gabrielli ,&nbsp;Mario Chiong ,&nbsp;Rodrigo Troncoso ,&nbsp;Luis Michea ,&nbsp;Sergio Lavandero","doi":"10.1016/j.lfs.2026.124248","DOIUrl":"10.1016/j.lfs.2026.124248","url":null,"abstract":"<div><h3>Background</h3><div>Heart failure with preserved ejection fraction (HFpEF) is a multifactorial syndrome characterized by diastolic dysfunction, metabolic disturbances, and skeletal muscle impairments. Exercise training has been recommended as non-pharmacological therapy for HFpEF. Yet its effects on cardiac, renal, skeletal muscle, and metabolic homeostasis remain incompletely understood.</div></div><div><h3>Aim</h3><div>We investigated the systemic effects of exercise training in the “two-hit” mouse model of HFpEF.</div></div><div><h3>Methods</h3><div>Male C57BL/6 N mice were assigned to either a sedentary HFpEF group (20 weeks) (<em>n</em> = 10) or a high-intensity interval training (HIIT) intervention for five weeks (training was initiated in the 15th week of the protocol) (n = 10), and a control group (<em>n</em> = 8). Cardiac function was assessed via echocardiography, while glucose metabolism, renal function, and skeletal muscle adaptations were evaluated through metabolic assays, histological analyses, and molecular studies.</div></div><div><h3>Results</h3><div>HIIT reduced diastolic dysfunction, as indicated by a slightly lower E/e′ ratio and reduced myocardial collagen deposition. Skeletal muscle integrity was improved, with a higher proportion of oxidative fibers in the gastrocnemius, while the quadriceps showed hypertrophy in both oxidative and less oxidative fibers. It also promotes an anabolic environment and mitochondrial enhancement. Force generation was also increased. Furthermore, HIIT reduced insulin levels without affecting renal function but decreased markers of kidney damage.</div></div><div><h3>Conclusions</h3><div>These findings demonstrate that HIIT attenuates diastolic and skeletal muscle dysfunction in the two-hit HFpEF mice model. Understanding how exercise training influences HFpEF phenotypes could provide novel insights into therapeutic strategies for patients with cardiovascular and metabolic comorbidities.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"389 ","pages":"Article 124248"},"PeriodicalIF":5.1,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146081260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced antiproliferative and anti-inflammatory effects of combined metformin, tadalafil, and tamsulosin in a rat model of testosterone-induced benign prostatic hyperplasia 二甲双胍、他达拉非和坦索罗辛联合应用在睾丸激素诱导的良性前列腺增生大鼠模型中的抗增殖和抗炎作用增强
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-27 DOI: 10.1016/j.lfs.2026.124240
Samar S. Khalaf , Aya M. Sherif , Eman T. Mehanna , Ranwa A. Elrayess , Noha M. Mesbah , Dina M. Abo-Elmatty , Mohamed M. Hafez

Aims

Benign prostatic hyperplasia (BPH) is a common condition in aging men, associated with hormonal imbalances, oxidative stress, and inflammation. This study evaluated the effects of metformin, tadalafil, and tamsulosin administered individually or in combination on testosterone-induced BPH.

Materials and methods

Following BPH induction, 48 male Wistar rats were divided into six groups: normal control, BPH control, and four treatment groups receiving metformin (500 mg/kg/day), tadalafil (2 mg/kg/day), tamsulosin (10 μg/kg/day), or their combination for two weeks. Serum levels of urea, creatinine, uric acid, reduced glutathione (GSH), and malondialdehyde (MDA) were measured using enzymatic colorimetric assays. Prostate tissue levels of prostate-specific antigen (PSA), estradiol, dihydrotestosterone (DHT), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and tumor necrosis factor-alpha (TNF-α) were analyzed via ELISA. mRNA expression of cyclooxygenase-2 (COX-2), transforming growth factor β-2 (TGFβ-2), insulin growth factor-2 (IGF-2), and bone morphogenetic protein 5 (BMP5) was assessed by quantitative real-time PCR.

Key findings

Histopathological examination confirmed BPH induction through increased prostate weight and prostate index. While monotherapies alleviated BPH-related changes, com-bination therapy showed superior antioxidant activity and significantly improved kidney function markers. It also markedly reduced PSA, estradiol, and DHT levels, along with significant downregulation of COX-2, TGFβ-2, IGF-2, BMP5, NF-κB, and TNF-α.

Significance

although individual treatments provided benefits, their combined use enhanced therapeutic outcomes through modulation of oxidative stress, inflammation, and androgenic activity in BPH management.
目的:良性前列腺增生(BPH)是老年男性的常见病,与激素失衡、氧化应激和炎症有关。本研究评估了二甲双胍、他达拉非和坦索罗辛单独或联合使用对睾丸激素诱导的前列腺增生的影响。材料与方法雄性Wistar大鼠诱导BPH后,48只分为正常对照组、BPH对照组和4个治疗组,分别给予二甲双胍(500 mg/kg/d)、他达拉非(2 mg/kg/d)、坦索罗辛(10 μg/kg/d)或联合用药2周。采用酶比色法测定血清尿素、肌酐、尿酸、还原性谷胱甘肽(GSH)和丙二醛(MDA)水平。ELISA法检测前列腺组织中前列腺特异性抗原(PSA)、雌二醇、二氢睾酮(DHT)、活化B细胞核因子κB轻链增强子(NF-κB)、肿瘤坏死因子α (TNF-α)水平。采用实时荧光定量PCR检测环氧化酶-2 (COX-2)、转化生长因子β-2 (tgf - β-2)、胰岛素生长因子-2 (IGF-2)、骨形态发生蛋白5 (BMP5) mRNA表达。病理组织学检查通过增加前列腺重量和前列腺指数证实BPH诱导。虽然单药治疗减轻了bph相关的变化,但联合治疗显示出更好的抗氧化活性和显著改善肾功能指标。它还显著降低PSA、雌二醇和DHT水平,同时显著下调COX-2、tgf - β-2、IGF-2、BMP5、NF-κB和TNF-α。虽然单独治疗有好处,但它们的联合使用通过调节BPH管理中的氧化应激、炎症和雄激素活性来增强治疗效果。
{"title":"Enhanced antiproliferative and anti-inflammatory effects of combined metformin, tadalafil, and tamsulosin in a rat model of testosterone-induced benign prostatic hyperplasia","authors":"Samar S. Khalaf ,&nbsp;Aya M. Sherif ,&nbsp;Eman T. Mehanna ,&nbsp;Ranwa A. Elrayess ,&nbsp;Noha M. Mesbah ,&nbsp;Dina M. Abo-Elmatty ,&nbsp;Mohamed M. Hafez","doi":"10.1016/j.lfs.2026.124240","DOIUrl":"10.1016/j.lfs.2026.124240","url":null,"abstract":"<div><h3>Aims</h3><div>Benign prostatic hyperplasia (BPH) is a common condition in aging men, associated with hormonal imbalances, oxidative stress, and inflammation. This study evaluated the effects of metformin, tadalafil, and tamsulosin administered individually or in combination on testosterone-induced BPH.</div></div><div><h3>Materials and methods</h3><div>Following BPH induction, 48 male Wistar rats were divided into six groups: normal control, BPH control, and four treatment groups receiving metformin (500 mg/kg/day), tadalafil (2 mg/kg/day), tamsulosin (10 μg/kg/day), or their combination for two weeks. Serum levels of urea, creatinine, uric acid, reduced glutathione (GSH), and malondialdehyde (MDA) were measured using enzymatic colorimetric assays. Prostate tissue levels of prostate-specific antigen (PSA), estradiol, dihydrotestosterone (DHT), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and tumor necrosis factor-alpha (TNF-α) were analyzed via ELISA. mRNA expression of cyclooxygenase-2 (COX-2), transforming growth factor β-2 (TGFβ-2), insulin growth factor-2 (IGF-2), and bone morphogenetic protein 5 (BMP5) was assessed by quantitative real-time PCR.</div></div><div><h3>Key findings</h3><div>Histopathological examination confirmed BPH induction through increased prostate weight and prostate index. While monotherapies alleviated BPH-related changes, com-bination therapy showed superior antioxidant activity and significantly improved kidney function markers. It also markedly reduced PSA, estradiol, and DHT levels, along with significant downregulation of COX-2, TGFβ-2, IGF-2, BMP5, NF-κB, and TNF-α.</div></div><div><h3>Significance</h3><div>although individual treatments provided benefits, their combined use enhanced therapeutic outcomes through modulation of oxidative stress, inflammation, and androgenic activity in BPH management.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"389 ","pages":"Article 124240"},"PeriodicalIF":5.1,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146080721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
STAT1/SLC31A1 signaling promotes diabetic retinopathy progression by mediating cuproptosis-induced M1 polarization in microglial cells STAT1/SLC31A1信号通过介导cuprotic诱导的小胶质细胞M1极化促进糖尿病视网膜病变的进展
IF 5.1 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-27 DOI: 10.1016/j.lfs.2026.124241
Jiayang Huang , Qiang Hu , Xue Zhang , Hongsong Peng , Shan Luo , Zhangxin Huang , Jitian Guan , Ali Hafezi-Moghadam , Bo Jiang , Dawei Sun
One of the main causes of vision impairment in diabetics is diabetic retinopathy (DR). However, the molecular mechanisms controlling its progression remains incompletely known. In this research, we identified the STAT1/SLC31A1 signaling pathway as a key regulator of cuproptosis-induced M1 polarization in microglial cells, thereby contributing to the pathogenesis of DR. STAT1 expression was markedly elevated under settings of high glucose (HG), both in in vitro experiments and in streptozotocin (STZ)-induced diabetic mouse models. Mechanistically, STAT1 transcriptionally upregulated the copper transporter SLC31A1, leading to copper accumulation and enhanced cuproptosis, as indicated by decreased levels of L-DLAT, FDX1, and NDUFS8. This cellular stress promoted M1 polarization and increased the expression of pro-inflammatory cytokines. Inhibition of either STAT1 or SLC31A1 significantly attenuated HG-induced cuproptosis and microglial activation. In vivo, STAT1 inhibition reduced retinal inflammation and structural damage, supporting its pathological role in DR progression. These findings confirm that the STAT1/SLC31A1/cuproptosis axis is a critical driver of microglial polarization and retinal injury and imply that SLC31A1 may act as DR's potential therapeutic target.
糖尿病视网膜病变(DR)是糖尿病患者视力损害的主要原因之一。然而,控制其进展的分子机制仍不完全清楚。在本研究中,我们发现STAT1/SLC31A1信号通路是铜胞嘧啶诱导的小胶质细胞M1极化的关键调节因子,从而参与dr的发病机制,在体外实验和STZ诱导的糖尿病小鼠模型中,STAT1的表达在高糖(HG)环境下显著升高。从机制上讲,STAT1通过转录上调铜转运蛋白SLC31A1,导致铜积累和铜沉积增强,如L-DLAT、FDX1和NDUFS8水平降低所示。这种细胞应激促进了M1极化,增加了促炎细胞因子的表达。抑制STAT1或SLC31A1均可显著减弱hg诱导的铜突起和小胶质细胞活化。在体内,STAT1抑制可减少视网膜炎症和结构损伤,支持其在DR进展中的病理作用。这些发现证实STAT1/SLC31A1/ cuprotosis轴是小胶质细胞极化和视网膜损伤的关键驱动因素,并暗示SLC31A1可能作为DR的潜在治疗靶点。
{"title":"STAT1/SLC31A1 signaling promotes diabetic retinopathy progression by mediating cuproptosis-induced M1 polarization in microglial cells","authors":"Jiayang Huang ,&nbsp;Qiang Hu ,&nbsp;Xue Zhang ,&nbsp;Hongsong Peng ,&nbsp;Shan Luo ,&nbsp;Zhangxin Huang ,&nbsp;Jitian Guan ,&nbsp;Ali Hafezi-Moghadam ,&nbsp;Bo Jiang ,&nbsp;Dawei Sun","doi":"10.1016/j.lfs.2026.124241","DOIUrl":"10.1016/j.lfs.2026.124241","url":null,"abstract":"<div><div>One of the main causes of vision impairment in diabetics is diabetic retinopathy (DR). However, the molecular mechanisms controlling its progression remains incompletely known. In this research, we identified the STAT1/SLC31A1 signaling pathway as a key regulator of cuproptosis-induced M1 polarization in microglial cells, thereby contributing to the pathogenesis of DR. STAT1 expression was markedly elevated under settings of high glucose (HG), both in in vitro experiments and in streptozotocin (STZ)-induced diabetic mouse models. Mechanistically, STAT1 transcriptionally upregulated the copper transporter SLC31A1, leading to copper accumulation and enhanced cuproptosis, as indicated by decreased levels of L-DLAT, FDX1, and NDUFS8. This cellular stress promoted M1 polarization and increased the expression of pro-inflammatory cytokines. Inhibition of either STAT1 or SLC31A1 significantly attenuated HG-induced cuproptosis and microglial activation. In vivo, STAT1 inhibition reduced retinal inflammation and structural damage, supporting its pathological role in DR progression. These findings confirm that the STAT1/SLC31A1/cuproptosis axis is a critical driver of microglial polarization and retinal injury and imply that SLC31A1 may act as DR's potential therapeutic target.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"389 ","pages":"Article 124241"},"PeriodicalIF":5.1,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146081265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Life sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1